Genentech: Baris Bingol | Principal Scientist, Neuroscience
Comparison of neutralizing antibody responses against SARS‐CoV‐2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? - Terpos - 2021 -
CHUNLONG CHEN | Institut Curie
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients - ScienceDirect
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Molecular Mechanisms and Models of Aging, Volume 1119 (Annals of the New York Academy of Sciences): 9781573316866: Gonos, Efstathios S., Trougakos, Ioannis P., Chondrogianni, Niki: Books - Amazon.com
Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine - Terpos - 2021 - American Journal of Hematology - Wiley Online Library
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
The Speakers – ICSA 2019 Athens
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine | SpringerLink
Vaccines | Free Full-Text | SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment - Abstract - Europe PMC
Loop | Ioannis Trougakos
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Universal Design: A Step toward Successful Aging – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
University of Athens | Tascmar
